CLL is the most common type of leukemia in adults in the Western world. There is evidence that genetic components contribute to the aetiology of CLL, but no definitive susceptibility genes have been identified.
This project is studying the role of immune cells in the regulation of disease progression. The Institute is in a unique position to study over one hundred patients with sequential blood samples. Preliminary data has demonstrated interesting results in the analysis of immune cells in these patients. This work has the potential of identifying new immune checkpoints that may lead to future immune treatments for leukaemias.
Group Leaders
- Professor George Kannourakis
Scientists
- Dr Sharon Olsen
- Dr Monirul Islam
